CATALOGO DEI PRODOTTI DELLA RICERCA

GAJOFATTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.178
EU - Europa 4.049
AS - Asia 1.521
AF - Africa 55
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 6
Totale 9.831
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.159
CN - Cina 1.186
GB - Regno Unito 1.113
IT - Italia 988
SE - Svezia 423
FR - Francia 346
IE - Irlanda 301
RU - Federazione Russa 270
DE - Germania 213
FI - Finlandia 197
SG - Singapore 113
VN - Vietnam 67
UA - Ucraina 56
EG - Egitto 46
KR - Corea 35
BE - Belgio 34
IR - Iran 25
IN - India 19
JP - Giappone 19
CZ - Repubblica Ceca 17
CA - Canada 15
CH - Svizzera 15
HK - Hong Kong 14
TR - Turchia 13
AU - Australia 12
MK - Macedonia 11
NL - Olanda 11
ES - Italia 9
GR - Grecia 9
IL - Israele 8
EU - Europa 7
NO - Norvegia 6
SD - Sudan 5
DK - Danimarca 4
PL - Polonia 4
AT - Austria 3
CL - Cile 3
CY - Cipro 3
HU - Ungheria 3
JO - Giordania 3
LV - Lettonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
DO - Repubblica Dominicana 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PA - Panama 1
SC - Seychelles 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 9.831
Salva come PNG Salva come JPEG
Città #
Southend 987
Chandler 786
Ashburn 424
Woodbridge 382
Ann Arbor 374
Jacksonville 331
Dublin 301
Beijing 241
Verona 188
Houston 147
New York 138
Wilmington 126
Lawrence 122
Princeton 122
Jinan 107
Nanjing 99
Hebei 88
Shenyang 85
Singapore 71
Boardman 70
Milan 69
Helsinki 68
Washington 55
Tianjin 44
Dong Ket 43
Lancaster 43
Redwood City 42
Zhengzhou 41
Ningbo 40
Changsha 38
Haikou 37
Nanchang 37
Hangzhou 35
Redmond 35
Brussels 34
Taiyuan 29
Sindelfingen 28
Taizhou 27
Rome 24
Cairo 23
Seattle 23
Seoul 22
Fuzhou 21
Guangzhou 21
Los Angeles 21
Dearborn 20
Falls Church 20
Tehran 20
Bologna 19
Jiaxing 19
Norwalk 18
Padova 18
Naples 16
Olomouc 15
Catania 14
Clearwater 13
Lanzhou 13
Tokyo 12
Düsseldorf 11
Kent 11
Seongbuk-gu 11
Skopje 11
Auburn Hills 10
Riva 10
Tappahannock 10
Fairfield 9
Florence 9
Kemerovo 9
Brescia 8
Dongguan 8
Hong Kong 8
Al Mansurah 7
Bisenti 7
Bolzano 7
Bronte 7
Loreggia 7
Paris 7
Arco 6
Bari 6
Phoenix 6
Sassari 6
Shanghai 6
Cagliari 5
Catanzaro 5
Chicago 5
Chions 5
Dallas 5
Genoa 5
Genova 5
Lappeenranta 5
Lugano 5
Orzivecchi 5
Seriate 5
Sydney 5
Trento 5
Athens 4
Buffalo 4
Fairport 4
Frankfurt am Main 4
London 4
Totale 6.588
Salva come PNG Salva come JPEG
Nome #
Psicologia positiva e disabilità: affrontare le sfide del futuro nell'adulto con disabilità acquisita, cronica e progressiva 357
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor Treatment of multiple sclerosis 266
Gestione degli eventi avversi dei farmaci modificanti il decorso della malattia nella sclerosi multipla 187
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 172
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 135
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 125
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 124
Analisi delle alterazioni funzionali dell’arto superiore e dell’attività muscolare mediante emgs in pazienti con sclerosi multipla: uno studio “cross-sectional” 118
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 117
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 117
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 114
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 113
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 110
GLI EFFETTI DI DUE DIVERSI TIPI DI TRATTAMENTO MOTORIO SULLE FUNZIONI COGNITIVE IN PAZIENTI CON SCLEROSI MULTIPLA 109
A case of multifocal CIS with unusual MRI features suggestive of Balo's concentric sclerosis 107
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 107
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 106
Risk factors for post-polio syndrome among an Italian population: a case-control study. 103
Cognitive onset in multiple sclerosis 103
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 102
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 101
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 100
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 98
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 97
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 97
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 96
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 95
Clinical and demographic predictors of response to first-line therapies in relapsing-remitting multiple sclerosis 95
A case of acute fulminant multiple sclerosis treated with alemtuzumab 93
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 92
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis 91
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 91
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 91
HCV-related nervous system disorders. 89
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 89
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 88
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 88
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 86
Response to Nagai et al. 86
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 84
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 84
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 83
Brentuximab vedotin: axonal microtubule's Apollyon 83
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 82
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 82
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 82
EFFECTIVENESS OF A SENSORIMOTOR INTEGRATION TRAINING ON BALANCE DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED TRIAL 81
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 80
Epilepsy in multiple sclerosis: The role of temporal lobe damage 80
Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children 79
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 79
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 78
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 78
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 77
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 77
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 77
"If you can't control the wind, adjust your sail": tips for post-pandemic benefit finding from young adults living with multiple sclerosis. A qualitative study 77
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 77
Long survival and clinical stability in Marburg's variant multiple sclerosis. 76
Prognostic factors of acute partial transverse myelitis. 75
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 75
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 75
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 75
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 75
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 74
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 74
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis 74
A bio-psycho-social co-created intervention for young adults with multiple sclerosis (ESPRIMO): rationale and study protocol for a feasibility study 74
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey 74
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 73
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 73
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 72
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 72
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study 72
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 71
Amyloid myopathy: an intriguing diagnosis 71
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 69
Prognostic indicators of “benign” clinical course in multiple sclerosis patients. 68
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) 68
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 68
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 65
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure 64
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 64
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. 63
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 63
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 62
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 62
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 62
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: an Italian multi-centre study 62
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 62
Therapeutic strategies for relapsing-remitting multiple sclerosis: a special focus on reduction of grey matter damage as measured by brain atrophy. 60
Tumor-like multiple sclerosis: three cases misdiagnosed as primary brain neoplasm 60
Impact of switching first-line disease-modifying therapy after treatment failure in relapsing-remitting multiple sclerosis 59
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives 58
e-ESPRIMO: An e-health biopsychosocial intervention for young adults with Multiple sclerosis and medium/high disability. Co-creation phase 57
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 56
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 56
Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? 55
Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date 55
Evaluating upper upper limb dysfunctions in patients with multiple sclerosis: an electromyography cross sectional study 55
Totale 8.873
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.016
article - articoli 30.062
book - libri 0
conference - conferenze 950
curatela - curatele 0
other - altro 239
patent - brevetti 0
selected - selezionate 0
volume - volumi 765
Totale 64.032
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020890 0 22 19 55 180 72 153 30 52 114 91 102
2020/20211.169 142 223 79 116 137 103 28 41 65 35 104 96
2021/20221.177 98 418 31 123 27 23 11 74 36 32 74 230
2022/20232.274 153 291 212 372 175 483 30 142 246 30 88 52
2023/20241.867 65 114 181 157 241 402 92 154 20 107 178 156
2024/2025279 169 110 0 0 0 0 0 0 0 0 0 0
Totale 10.040